New One-Day Surface Metrology and Tribology Class, November 14, 2024

LIVONIA, MI (July 7, 2024) – Registration is now open for the new one-day Surface Metrology and Tribology class which will be held in Livonia, Michigan, Nov. 14, 2024. The 1-day class offers a unique opportunity to learn the fundamentals of surface roughness, friction, and wear analysis, and their applications in manufacturing and product development.…

Read More

New TrialAssure LINK® AI 2.0 Medical Writing Technology Debuts to the Pharmaceutical Industry at the DIA Annual Conference in San Diego

SAN DIEGO (June 17, 2024) – TrialAssure, a leading provider of pharmaceutical technology advancing clinical trial disclosure, data sharing, and transparency, announced today the release of TrialAssure LINK® AI 2.0. This new version is updated and designed to assist pharmaceutical, biotechnology companies, clinical research organizations, and other service providers in creating drafts of common regulatory…

Read More

Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com

ANN ARBOR, MI, JUNE 5, 2024—Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of which are multiplex assays, including panels for wound, upper respiratory, urinary tract,…

Read More

Stryker to Acquire Artelon, Expanding Soft Tissue Fixation Solutions

Stryker (NYSE: SYK), a global medical technology leader, has signed an agreement to acquire Artelon, a company specializing in soft tissue fixation products for foot and ankle and sports medicine procedures. This acquisition aims to bolster Stryker’s capabilities in ligament and tendon reconstruction. Artelon’s synthetic technology enhances biological and mechanical reconstruction, with over 60,000 implantations…

Read More

TrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond

TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ANONYMIZE allows users across the pharmaceutical industry the ability to perform data, document, and image anonymization and redaction using machine learning (ML), natural language processing (NLP), and artificial intelligence (AI)…

Read More

90,000 sq. ft. Expansion of Grand River Aseptic Manufacturing’s Finishing and Warehouse Center is Complete

 Grand River Aseptic Manufacturing (“GRAM”), a leading sterile injectable contract manufacturer of biologics, small molecules, and vaccines, announces the completion of its finishing and warehouse center expansion. The expansion added 90,000 sq. ft. to the existing 110,000 sq. ft., totaling 200,000 sq. ft. of sophisticated inspection, packaging, testing, and warehouse capabilities. Grand River Aseptic Manufacturing…

Read More

Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies

ANN ARBOR, MI, FEBRUARY 22, 2024 – Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits. The LipidLaunch™ product line is the latest addition to the company’s portfolio of LNP research tools and reflects the company’s legacy of providing high-quality lipids…

Read More

TrialAssure Uses Artificial Intelligence to Create Plain Language Summaries for 50,000 Studies Listed on ClinicalTrials.Gov

ORIGINAL SOURCE TrialAssure’s proprietary AI-technology can aid in making clinical trial results available more quickly to all trial participants and the public The equivalent of one million work hours completed in less than one day using AI in honor of Health Literacy Month Plain language summaries to be released over a five-week period by disease…

Read More

TrialAssure Announces AI Generative Text Partnership with Top Clinical Research Organization MMS on New Medical Writing Initiative

TrialAssure, a leading software-as-a-service (SaaS) provider advancing clinical trial disclosure, data sharing, and transparency, announced today that it is collaborating with MMS, a global clinical research organization, on a new artificial intelligence (AI) initiative aimed at developing generative text specifically for medical writing in the field of drug development. The primary focus of this collaboration…

Read More